| 000 | 01674 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515172140.0 | ||
| 264 | 0 | _c20091130 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1471-2172 | ||
| 024 | 7 |
_a10.1186/1471-2172-10-28 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShor, Boris | |
| 245 | 0 | 0 |
_aA kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice. _h[electronic resource] |
| 260 |
_bBMC immunology _cMay 2009 |
||
| 300 |
_a28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCatalytic Domain _xgenetics |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEmbryonic Development _xgenetics |
| 650 | 0 | 4 | _aGene Knock-In Techniques |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 |
_aImmune System _xembryology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _ximmunology |
| 650 | 0 | 4 |
_aPhosphotransferases (Alcohol Group Acceptor) _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aTacrolimus Binding Protein 1A _xantagonists & inhibitors |
| 700 | 1 | _aCavender, Druie | |
| 700 | 1 | _aHarris, Crafford | |
| 773 | 0 |
_tBMC immunology _gvol. 10 _gp. 28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2172-10-28 _zAvailable from publisher's website |
| 999 |
_c18883627 _d18883627 |
||